Results 71 to 80 of about 7,162 (211)
Atypical hemolytic uremic syndrome precipitated by thyrotoxicosis: a case report
Background Autoimmune thyroid disease (AITD) has a complex pathogenesis and is associated with the development of autoimmunity against the thyroid. Graves’ disease and Hashimoto’s thyroiditis are the two main types of AITD, and they are characterized by ...
Ling Hou, Yue Du
doaj +1 more source
British Journal of Haematology, Volume 208, Issue 6, Page 2311-2314, June 2026.
Mamie M. Thant +4 more
wiley +1 more source
Indigenous ways of sharing and developing knowledge survive in ceremony, songs, proverbs, storytelling and purposeful dialogues. Wānanga (space for knowledge sharing) is the epitome of traditional knowledge transmission—grounded in Indigenous practice and worldview, allowing for the co‐creation of new knowledge and passing down of inherited knowledge ...
Deborah Heke +3 more
wiley +1 more source
Read the free Plain Language Summary for this article on the Journal blog. Abstract The nested subset pattern (nestedness) has been widely used to explain species distributions in island and fragmented systems. Mountain sky islands serve as critical natural laboratories for understanding the evolutionary consequences of geographic isolation and climate
Caiwen Zhang +5 more
wiley +1 more source
Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura [PDF]
Background Atypical hemolytic uremic syndrome (aHUS) involves dysregulation of the complement system, but whether this also occurs in thrombotic thrombocytopenic purpura (TTP) remains unclear.
Baker, R.I. +7 more
core
Real-world evidence from the Global aHUS Registry confirms the safety and effectiveness of switching to ravulizumab from eculizumab in patients with aHUS: a plain language summary [PDF]
Registry; Atypical hemolytic uremic syndrome; RavulizumabRegistre; Síndrome hemolític urèmic atípic; RavulizumabRegistro; Síndrome hemolítico urémico atípico; RavulizumabWhat is aHUS?
Greenbaum, Larry +3 more
core +1 more source
This summary gives an overview of three published articles that report the results of research studies of ravulizumab, an approved treatment for people with atypical hemolytic uremic syndrome (often shortened to aHUS).
Michal Nowicki, Nikoleta Printza
doaj +1 more source
Atypical haemolytic uremic syndrome (aHUS) is a rare disorder characterised by complement-mediated thrombotic microangiopathy (TMA). Despite clinical guidelines, the diagnosis and treatment of aHUS in its early stages remains challenging.
Yoshitaka Tatematsu +8 more
doaj +1 more source
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome
Thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uraemic syndrome (aHUS) are acute, rare life-threatening thrombotic microangiopathies that require rapid diagnosis and treatment.
Goodship, T, Scully, M
core

